The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

Submitted by admin on March 9, 2017 - 11:25am
Source: 
TheStreet.com
News Tags: 
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Headline: 
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle

Do Not Allow Advertisers to Use My Personal information